positions available now

Monthly Archives: May 2018

The long road to PBS listing for Orkambi

Orkambi (lumacaftor and ivacaftor), a treatment for cystic fibrosis (CF), will go before the PBAC for a fourth time at the upcoming July 2018 PBAC meeting. So far, the road to reimbursement has been filled with multiple rejections, a strong … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , , , | Comments Off on The long road to PBS listing for Orkambi

PBAC Meeting Agenda – July 2018

The July 2018 PBAC Meeting is scheduled from 4 to 6 Jul 2018. Here, the Commercial Eyes Market Access team provides an overview of the meeting agenda, including submissions relating to biosimilars lodged for this meeting.     The Commercial … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , , , , | Comments Off on PBAC Meeting Agenda – July 2018

PBAC Meeting Outcomes – March 2018

The March 2018 PBAC Meeting Outcomes were published on 20th April 2018. With 71 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including an additional analysis conducted on oncology submissions which have … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , , | Comments Off on PBAC Meeting Outcomes – March 2018
Copyright © 2014 Commercial Eyes